Tag: coexclusive
Novavax: Co-exclusive licensing agreement with Sanofi
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Sanofi and Novavax enter into co-exclusive licensing agreement
(Boursier.com) — As part of the ambition of Sanofi to develop a diversified portfolio of best-in-class vaccines, the company announces the conclusion of a co-exclusive licensing agreement with Novavaxa biotechnology…
Press release: Sanofi and Novavax enter into a co-exclusive licensing agreement for the co-commercialization of a COVID-19 vaccine and the development of combined influenza – COVID-19 vaccines – 05/10/2024 at 08:00
Sanofi and Novavax enter into a co-exclusive licensing agreement for the co-commercialization of a COVID-19 vaccine and the development of combined influenza – COVID-19 vaccines The agreement, which will combine…
Sanofi: co-exclusive licensing agreement with Novavax – 05/10/2024 at 08:53
(CercleFinance.com) – Sanofi announces the conclusion of a co-exclusive licensing agreement with Novavax, for the co-marketing of a Covid-19 vaccine and the development of combined influenza-Covid-19 vaccines, as well as…
Sanofi and Novavax enter into a co-exclusive licensing agreement – 05/10/2024 at 08:55
(AOF) – Sanofi and Novavax enter into a co-exclusive licensing agreement for the co-commercialization of a COVID-19 vaccine and the development of combined influenza – COVID-19 vaccines. The agreement, which…